Takuya Mizuno

19PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersCancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 22, 2026
Caninized PD-1 monoclonal antibody in oral malignant melanoma: efficacy and exploratory biomarker analysis.

Masaya Igase, Kenji Hagimori, Sakuya Inanaga

|Sep 18, 2025
Lactic acid regulates antitumor immunity in canine invasive urothelial carcinoma.

Taiki Kato, Nao Okauchi, Tomoki Motegi

|Jun 27, 2025
Characterization of anti-canine CD20 antibody 4E1-7-B_f and comparison with commercially available anti-human CD20 antibodies.

Takuya Mizuno, Yukinari Kato, Toshihiro Tsukui

|May 07, 2024
Identification of hypoxia-induced metabolism-associated genes in canine tumours.

Taiki Kato, Masashi Sakurai, Kenji Watanabe

|Feb 04, 2024
Proof-of-concept study of the caninized anti-canine programmed death 1 antibody in dogs with advanced non-oral malignant melanoma solid tumors.

Masaya Igase, Sakuya Inanaga, Shoma Nishibori

|Nov 18, 2022
Defucosylated Mouse-Dog Chimeric Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H77Bf) Exerts Antitumor Activities in Mouse Xenograft Models of Canine Osteosarcoma.

Ren Nanamiya, Tomokazu Ohishi, Hiroyuki Suzuki

Pageof 4

Frequent Collaborators

5 joint publications

Yukinari Kato

3 joint publications

James K Chambers

3 joint publications

Kazuyuki Uchida

3 joint publications

Tomokazu Ohishi